Opinion|Videos|September 6, 2024

Efficacy of Biomarker Test Results

Author(s)Benjamin H. Lowentritt, MD, FACS, Brian Richardson, MD, Angelo A. Baccala, MD

The panel examines the challenges associated with effectively interpreting and applying biomarker test results in prostate cancer management and treatment decision-making.

Episodes in this series

A panel of 4 experts on prostate cancer

EP. 1 Overview of Prostate Cancer

A panel of 4 experts on prostate cancer

EP. 2 Challenges of PSA as a Diagnostic Biomarker

A panel of 4 experts on prostate cancer

EP. 3 Role of Biomarker and Genetic Testing in Prostate Cancer Diagnosis

A panel of 4 experts on prostate cancer

EP. 4 Emerging Serum, Urine, and Tissue Biomarkers in the Clinical Setting

A panel of 4 experts on prostate cancer

EP. 5 High Risk Populations in the Development of Prostate Cancer

A panel of 4 experts on prostate cancer

EP. 6 Risk Stratification in Prostate Cancer Patients

A panel of 4 experts on prostate cancer

EP. 7 Challenges in Risk Assessment and Biomarkers in Treatment Recommendations

A panel of 4 experts on prostate cancer

EP. 8 Influences and Challenges of Biomarkers on Treatment Selection

A panel of 4 experts on prostate cancer

EP. 9 Efficacy of Biomarker Test Results

A panel of 4 experts on prostate cancer

EP. 10 Biomarker Use in Patients on Active Surveillance

A panel of 4 experts on prostate cancer

EP. 11 Use of Molecular Biomarkers Tests

A panel of 4 experts on prostate cancer

EP. 12 Integrating Biomarker Testing Into the Patient Care Journey

A panel of 4 experts on prostate cancer

EP. 13 AI and the Future of Biomarkers in Prostate Cancer

A panel of 4 experts on prostate cancer

EP. 14 Current Advancements in Biomarker Research

A panel of 4 experts on prostate cancer

EP. 15 Unmet Needs and Treatment Gaps in Prostate Cancer

EP. 16 Tim A. Richardson, MD, outlines key settings for genetic testing in prostate cancer

EP. 16 Tim A. Richardson, MD, outlines key settings for genetic testing in prostate cancer

EP. 17 Kara Cossis, PA-C, MPH, on the role of APPs in genetic testing

EP. 17 Kara Cossis, PA-C, MPH, on the role of APPs in genetic testing

EP. 18 Tim Richardson, MD, on genetic testing in the era of targeted therapies

EP. 18 Tim Richardson, MD, on genetic testing in the era of targeted therapies

EP. 19 Paul Sieber, MD, on the future of genetic testing in prostate cancer

EP. 19 Paul Sieber, MD, on the future of genetic testing in prostate cancer

Video content above is prompted by the following question:

How do you address the challenge of using biomarkers test results effectively?

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

The role of diet and lifestyle in prostate cancer care, with Lorelei A. Mucci, ScD, MPH

ByLorelei A. Mucci, ScD, MPH

September 11th 2026

Doublet or triplet? Urologists weighs in on mCSPC options

ByUrology Times staff

September 10th 2026

Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD

ByMartin Schoen, MD, PhD,Hannah Clarke

September 10th 2026

App-based intervention aims to increase PSA screening among Black men

ByHannah Clarke

September 9th 2026

The critical role of advocacy in urologic oncology

ByRuchika Talwar, MD,Lan Anh Galloway, MD

September 9th 2026

Latest CME

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

AI-generated profiles impersonate female urologists to market ED products online

Alternative BCG strains may help address ongoing supply challenges in NMIBC

Doublet or triplet? Urologists weighs in on mCSPC options

Pearls & Perspectives: Sexual Health and Intimacy in Midlife, With Karen Bigman, MBA

Prior auth, step therapy, and consolidation pressure: Independent urology's challenge